Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo

The delivery of anticancer agents to their subcellular sites of action is a significant challenge for effective cancer therapy. Peptides, which are integral to several oncogenic pathways, have significant potential to be utilised as cancer therapeutics due to their selectivity, high potency and lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Haggag, Yusuf A., Matchett, Kyle B., Falconer, Robert A., Isreb, Mohammad, Jones, Jason, Faheem, Ahmed, McCarron, Paul, El-Tanani, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406988/
https://www.ncbi.nlm.nih.gov/pubmed/30769871
http://dx.doi.org/10.3390/cancers11020222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406988/
https://www.ncbi.nlm.nih.gov/pubmed/30769871
http://dx.doi.org/10.3390/cancers11020222

Ejemplares similares